2-(0-chlorophenyl)-2-methylaminocyclohexanone (CI-581), a derivative of phencyclidine, was shown to depress the cardiovascular system in conscious rats and in rats anaesthetized with pentobarbitone and urethane. In pithed animals, however, there was a substantial rise in blood pressure, suggesting that CI-581 may act on the central cardiovascular regulatory mechanisms. The pressor response to CI-581 in pithed animals was considerably reduced by phenoxybenzamine and phentolamine. In reserpinized animals, the pressor response to CI-581 was abolished but could be restored by infusions with noradrenaline. Thus, CI-581 may act indirectly by releasing catecholamines from peripheral stores. In adrenalectomized rats, the increase in blood pressure elicited by CI-581 was abolished by pre-treatment with reserpine. The data indicate that the peripheral release of catecholamines by CI-581 may be derived from more than one storage site.
CI-581 or 2-(O-chlorophenyl)-2-methylaminocyclohexanone is a derivative of phencyclidine (Sernyl). The anaesthetic properties of CI-581 were investigated in laboratory animals and in man by McCarthy and Chen (1965) , Chen, Ensor and Bohner (1966) , and Domino, Chodoff and Corssen (1965) . These workers found that CI-581 produced a rapid and smooth surgical anaesthesia of short duration. Unlike phencyclidine, CI-581 is said to have no sedative, hypnotic or convulsive properties. However, as with phencyclidine, CI-581 at anaesthetic dose levels affects many other physiological processes including the cardiovascular system. For example, Chen, Glazko and Kaump (1967) , reported that an intravenous injection of CI-581 resulted in an initial transient fall in arterial pressure followed by a prolonged pressor response in anaesthetized and unanaesthetized dogs. The heart rate was also substantially increased. In anaesthetized rats, an injection of CI-581 could result either in a fall or rise in blood pressure. In man, CI-581 considerably increased both the systolic and diastolic pressures and the heart rate (Domino, Chodoff and Corssen, 1965) and these effects are likely to preclude its widespread clinical accep-* The approved name is ketamine.
tance (Robertson, 1967) . The mechanisms underlying the cardiovascular changes brought about by CI-581 are not clear, although it has been suggested that it may act on the central cardiovascular regulatory mechanisms (Chen, Glazko and Kaump, 1967) .
It is, important therefore, to define the cardiovascular effects in order to anticipate possible clinical conditions in which the use of such an anaesthetic might be precluded or indicated. An investigation on the cardiovascular effects of CI-581 in rats is reported here.
METHODS
Male rats of the Sprague-Dawley strain weighing between 200 and 300 g were used. Conscious rats were prepared under short ether anaesthesia and they were kept in restraining cages after recovery from the anaesthetic. Anaesthetized rats were either given pentobarbitone 30 mg/kg or urethane 1 g/kg intraperitoneally. Pithed rats were prepared by the method of Brown and Gillespie (1957 animals were prepared under ether anaesthesia 3 days before the experiments. The adrenalectomized rats were fed on normal laboratory diet and given a solution of 1 per cent NaCl to drink. Rats were treated with reserpine (Serpasil, Ciba) by giving 2.5 mg/kg intraperitoneally on 3 successive days. Experiments were performed on the 4th day. When adrenalectomized rats were given reserpine, this was done on the 4th postoperative day. They were given reserpine 1.0 mg/kg on the 5th day and 0.5 mg/kg on the 6th and 7th days. Experiments on these animals were made on the day following the last dose of reserpine.
Blood pressure was monitored from the common carotid artery via a Statham pressure transducer (P23AC) coupled to a Grass Polygraph (Model 5). The heart rate was determined from e.c.g. records. The drugs in solution were injected via a femoral vein.
The drugs used were 2-(O-chlorophenyl)-2-methylaminocyclohexanone hydrochloride (CI-581, Parke-Davis), phenoxybenzamine hydrochloride (SKF), phentolamine hydrochloride (Ciba) and noradrenaline bitartrate (Sigma). The concentrations referred to in the text are in terms of these salts. Drugs were dissolved or diluted in normal saline solution immediately before use.
RESULTS
Effects of C/-581 on arterial pressure and heart rate. Throughout the study, a dose of 2 mg/kg of CI-581 was used in the investigation. At this dose level, two patterns of responses were observed.
Vasodepressor response. This was observed in five animals in each of the various groups; they were the conscious rats, rats under urethane anaesthesia and those under pentobarbitone anaesthesia. As shown in table I, an intravenous injection of CI-581 caused the arterial pressure of conscious rats to fall by a mean value of 13.0 mm Hg (SE 3.0) and the heart rate by a mean of 55 beats/min (SE 8). This fall in blood pressure was transient ( fig. la) .
In the pentobarbitone treated rats, CI-581 injection caused a significant fall in arterial pressure, the mean fall being 30.6 mm Hg (SE 11.5; P<0.05). The heart rate was not significantly decreased, although there was a mean drop of 76 beats/min (SE 13). The results are shown in table I and figure lb.
The arterial pressure of animals under urethane anaesthesia also fell significantly following an injection of CI-581, as in the case of pentobarbitone treated rats (table I and The following experiments were carried out to investigate the mechanism(s) of vasopressor activity of CI-581 in pithed animals.
Effect of a-adrenergic receptor blockers on the
pressor action of C/-581 in pithed rats. Pretreatment of pithed animals with phenoxybenzamine (2 mg/kg), given by slow intravenous injection, markedly reduced the pressor activity of CI-581 (P<0.001, table III). This reduction was observed in five experiments and was also obtained with phentolamine 4 mg/kg ( fig. 2) .
Effect of reserpinization on the pressor action of
C/-581 in pithed rats. The pressor response to CI-581 in five pithed animals was virtually abolished when they were pretreated with reserpine (table IV and fig. 3 ). However, after infusion with noradrenaline 10 itg/kg over a period of 5 minutes, and when the arterial pressure had returned to its previous levels, the same intravenous injection of CI-581 again caused a rise in blood pressure. The data obtained suggest that noradrenaline was taken up into storage sites and was released again by CI-581.
Effect of a-adrenergic receptor blockers on the pressor action (mm Hg) of C/-581 in pithed rats (mean and SE).

Effect of bilateral adrenalectomy on the pressor
action of C/-581 in pithed rats. Bilateral adrenalectomy (5) reduced but, did not completely abolish the pressor response to CI-581 ( fig. 4a, b) . There was a consistent rise of a mean of 11 mm Hg (SE 1.0) in arterial pressure (table V) . This increase was, however, not seen in adrenalectomized rats previously treated with reserpine ( fig. 4c, d) . It thus appears that the release of noradrenaline and/or adrenaline which is responsible for the pressor action of CI-581 in pithed animals can come from several tissue stores including adrenal glands and sympathetic nerve endings. The results indicate that CI-581 depressed the cardiovascular system in conscious rats and in rats under pentobarbitone and urethane anaesthesia. However, CI-581 caused a marked rise in arterial pressure when the animal was pithed, suggesting that the cardiovascular depression produced by CI-581 in conscious and in anaesthetized animals may be centrally mediated. This view is shared by Chen, Glazko and Kaump (1967) who concluded from their studies in thiopentone treated rats that CI-581 depresses central cardiovascular regulatory mechanisms.
However, the reversal of these findings for CI-581 in pithed animals suggests that in addition the drug may possess a sympathomimetic activity. This pressor response to CI-581 was considerably reduced by the a -adrenergic receptor blockers, phenoxybenzamine and phentolamine. Interestingly, the pressor component of CI-581 in pentobarbitone treated dogs was also reduced, though not completely suppressed, by phenoxybenzamine (Chen, Glazko and Kaump, 1967) . Furthermore, these workers showed that this pressor activity was blocked in conscious dogs pretreated with chlorpromazine, a drug known to possess strong adrenergic blocking activity.
The peripheral sympathomimetic action of CI-581 is probably due to release of catecholamines from tissue stores, since its action was abolished in pithed animals pretreated with reserpine which is known to deplete tissue catecholamine stores (Bertler, Carlsson and Rosengren, 1956; Eranko and Hopsu, 1958; Shore, 1966) . Furthermore, the pressor response to CI-581 was restored by infusing the animals with noradrenaline.
Bilateral adrenalectomy did not, however, appear to abolish completely the pressor action of CI-581 on the pithed animals. A small rise in blood pressure was consistently present in these animals. Evidently, CI-581 not only affects the release of catecholamines from adrenergic nerve endings but also partially from the adrenal glands. This suggestion is supported by the experimental findings.
SOMMAIRE
II a ete demontre que le 2-(0-chlorophenyl)-2-methylaminocyclohexanone (CI 581), un derive de phencyclidine, inhibe le systeme cardiovasculaire chez le rat conscient et chez le rat anesthesie au pentobarbitone et urethane. Mais chez l'animal a moelle epiniere sectionnee, il y avait une augmentation importante de la pression sanguine, et ceci suggere que CI 581 pourrait agir sur les mecanismes regulateurs cardiovasculaires centraux. 
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